-
From Unstructured Text to Enriched Data: Evaluating Large Language Models for Clinical Information Extraction From Echocardiogram Reports
Sep 9, 2025, 16:22 PM -
Analysis of ATC Equivalent Group and Therapeutic Reference Code Distributions Based on Drug Price and Reimbursement Lists in Türkiye Between 2020 and 2025
Sep 9, 2025, 16:22 PM -
Prices And Reimbursement Conditions for Poly (ADP-RIBOSE) Polymerase Inhibitors (PARPi) Indicated for Ovarian Cancer in Spain
Sep 9, 2025, 16:22 PM -
Systematic Literature Review and Bayesian Network Meta-Analysis of Sugemalimab Plus Chemotherapy vs. Other First-Line Treatments for Metastatic Non-Small Cell Lung Cancer Without Sensitizing eGFR, ALK, ROS1, or RET Alterations
Sep 9, 2025, 16:22 PM -
Matching-Adjusted Indirect Comparison of Obecabtagene Autoleucel vs. Blinatumomab Inotuzumab Ozogamicin and Ponatinib in Relapsed or Refractory Adult B-cell Acute Lymphoblastic Leukemia
Sep 9, 2025, 16:22 PM -
Do Short-Term Outcome-Based Payments for Treatments Provide the Same Incremental Net Benefit As List Price Discounts?
Sep 9, 2025, 16:22 PM -
Equality Considerations in NICE Guidance of Medical Devices Digital and Diagnostic Technologies and Interventional Procedures
Sep 9, 2025, 16:22 PM -
Identification of Real-World Data to Study HAE Unmet Need: A Targeted Literature Review
Sep 9, 2025, 16:22 PM -
Optimizing Therapeutic Strategies for Multiple Sclerosis in Italy: A Budget Impact Analysis
Sep 9, 2025, 16:22 PM -
The Impact of Clinical Evidence on the Inclusion of Non-Small Cell Lung Cancer Drugs in Brazil's Supplementary Healthcare System
Sep 9, 2025, 16:22 PM -
Estimating Healthcare Resource Use Associated With the Treatment of Phenylketonuria in the United States
Sep 9, 2025, 16:22 PM -
The Cost-Effectiveness of Targeted-Release Form (TRF)-Budesonide for the Treatment of Adult Population With Immunoglobulin A Nephropathy (IgAN) in Greece
Sep 9, 2025, 16:22 PM -
Synthetic Data Generation vs. Simulated Treatment Comparison: Assessment of the Performance of a Novel Approach for Unanchored Indirect Treatment Comparisons
Sep 9, 2025, 16:22 PM -
Length of Stay (LOS) and Associated Healthcare Resource Use (HCRU) for a First Infusion of Axi-cel or Lisocel in Second Line for Large B-cell Lymphoma in France: Differences Observed From Comprehensive Hospital Databases
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness Assessment of Orphan Drugs in France: Key Insights from CEESP Reviews (2021-2024)
Sep 9, 2025, 16:22 PM -
Modeling the Healthcare Burden of Oral Corticosteroid Use in Mexico
Sep 9, 2025, 16:22 PM -
Mapping the Evidence on Interrelationships Between Cancer Stage Financial Toxicity (FT) and Health-Related Quality of Life (HRQoL)
Sep 9, 2025, 16:22 PM -
Uncovering Gender Disparities in Secondary Care for Major Adverse Cardiovascular Events (MACE): Insights From the Hospital Episodes Statistics (HES) Database
Sep 9, 2025, 16:22 PM -
AI-Enabled Extraction of eGFR and BRAF Testing Patterns in Advanced NSCLC: IMPACT-NSCLC, a Multicenter Real-World Study (2019-2024)
Sep 9, 2025, 16:22 PM -
Relevance of Quality Indicators for Supporting Patients’ Choice of Hospitals: An Online Survey
Sep 9, 2025, 16:22 PM
